Empagliflozin potently reduces sarcoplasmic Ca leak and increases Ca transient amplitude of human failing ventricular cardiomyocytes

Back

ESC Premium Access

Empagliflozin potently reduces sarcoplasmic Ca leak and increases Ca transient amplitude of human failing ventricular cardiomyocytes

Session: Heart Failure: new targets for treatment

Topic: Heart Failure

Speaker: Doctor J. Mustroph (Regensburg, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Julian Mustroph

University Hospital Regensburg, Regensburg (Germany)

0 follower

5 more presentations in this session

Angiotensin II-dependent activation of NADPH oxidase 4 contributes to muscle wasting in mice via downregulation of NF-E2-related factor 2

Speaker: Doctor T. Kadoguchi (Tokyo, JP)

Excessive mitochondrial reactive oxygen species emission from circulating blood cells is associated with severity of heart failure and exercise intolerance

Speaker: Doctor R. Shirakawa (Sapporo, JP)

Positive cardiac inotropy by carvedilol via unique beta-arrestin2-dependent SERCA2a stimulation

Speaker: Associate Professor A. Lymperopoulos (Fort Lauderdale, US)

HECTD3 attenuates cardiac hypertrophy acting as an E3 ligase of SUMO2

Speaker: Doctor A. Rangrez (Kiel, DE)

Access

Abstract

RNA methylation in cardiac hypertrophy and heart failure

Speaker: Mr E. Buchholz (Gottingen, DE)

Access

Abstract

Access the full session

Heart Failure: new targets for treatment

Speakers: Doctor J. Mustroph, Doctor T. Kadoguchi, Doctor R. Shirakawa, Associate Professor A. Lymperopoulos, Doctor A. Rangrez...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources